Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification.
Millen R, De Kort WWB, Koomen M, van Son GJF, Gobits R, Penning de Vries B, Begthel H, Zandvliet M, Doornaert P, Raaijmakers CPJ, Geurts MH, Elias SG, van Es RJJ, de Bree R, Devriese LA, Willems SM, Kranenburg O, Driehuis E, Clevers H.
Millen R, et al. Among authors: begthel h.
Med. 2023 May 12;4(5):290-310.e12. doi: 10.1016/j.medj.2023.04.003.
Med. 2023.
PMID: 37178682
Free article.